Canada: CETA – What Does It Mean For IP In Canada?


Almost a year following an agreement-in-principle between Canada and the European Union, the official full text of the Canada-European Union Comprehensive Economic and Trade Agreement (CETA) was released September 26, 2014. The 1500 page Agreement reflects most of what was previously articulated by the Canadian government in a summary produced after the agreement-in-principle. In the domain of intellectual property CETA stands to impact pharmaceuticals with respect to patent term restoration, appeal rights and data protection, as well as trademarks with respect to counterfeit goods and EU Geographical Indications.

With the text formally released, Canada and the EU member nations will now undertake measures to ratify the treaty. This is a process that has become more complex amid media reports that Germany still opposes certain sections of the Agreement. Regardless, there remains a long road before CETA is officially ratified, as each of the parties must now undertake the process of passing the Agreement through various stages in their individual legislatures. It will take still longer to consider how the Agreement will specifically be implemented, including the nature of amendments to applicable legislation.

Pharmaceutical Patents

Patent Term Restoration

Patent Term Restoration (PTR) is currently available in many industrialized nations, but not Canada. PTR provides additional incentives to pharmaceutical companies whose new drug approvals are delayed during the health regulatory marketing approval process. In these cases, patent protection may not be adequate, as delayed drug approval means that the patent covering a drug may expire on or before the date that approval is granted. CETA aims to lessen the impact of this problem in Canada by restoring up to two years of patent term.

This change will require an amendment to either the Patent Act or the Food and Drugs Act. The enacting provisions may be embodied in an amendment to a statute and/or by regulation. In the latter case, an amendment to either the Patent Act or the Food and Drugs Act will grant the regulation-making power necessary to create "Patent Term Restoration Regulations".

Appeal Rights and Duplicative Litigation under the PM(NOC) Regulations

At present, within days of an innovator losing an Application under the Patented Medicines (Notice of Compliance) Regulations ("PM(NOC) Regulations") the generic is often granted a Notice of Compliance, i.e., official approval to sell a copy cat drug in Canada. Canadian Courts have held that this renders any appeal by the innovative company moot. On the other hand, should the generic lose a proceeding under the PM(NOC) Regulations, the generic may appeal that decision to the Federal Court of Appeal and potentially even to the Supreme Court of Canada (for instance, Teva v. Pfizer (Viagra), 2012 SCC 60).

CETA will require that both parties under the PM(NOC) Regulations be granted a right of appeal. The aim of this requirement is to introduce balance and fairness to proceedings under PM(NOC) Regulations and permit research based companies to appeal negative decisions.

However, some issues with proceedings under the PM(NOC) Regulations will need to be addressed. Currently the PM(NOC) Regulations prescribe a 24-month window during which the entire Application must be resolved. If the innovator decides to appeal a decision, the 24-month period will likely have lapsed. Changes may be required to the PM(NOC) Regulations to address this issue. Another question is whether the generic's NOC will be held in abeyance pursuant to a stay pending the outcome on appeal or, whether the generic's NOC will be revoked should the innovator succeed on appeal.

A further issue that remains in Canada is that it is current practice for an innovator who loses a proceeding under the PM(NOC) Regulations to launch an action for patent infringement once the generic comes to market. Similarly, if the generic loses a proceeding under the PM(NOC) Regulations, it can initiate an action to impeach any pertinent patents. Both of these actions proceed under the Patent Act. If the right to appeal is available to both parties it is questionable whether, and under what circumstances, such duplicate proceedings will be permitted.

To come into line with CETA's right of appeal for both parties, the government will be required to amend the PM(NOC) Regulations. Since these regulations were enacted pursuant to a regulation-making power set out in s 55.2 of the Patent Act, it is unlikely that amendment to the Patent Act will be required.

Data Protection

CETA repeats Canada's current term of data protection (i.e., 6 years before a generic can file an Abbreviated New Drug Submission if it relies on the innovator's data, and 8 years before issuance of a NOC to the generic). The 8 years of data protection does not differ from current Canadian law. Thus, no changes are required to the Data Protection Regulations.

Investor-State Dispute Settlement in Intellectual Property

A contentious issue of CETA has been the Investor State Dispute Settlement Chapter. Arbitration clauses are common in trade agreements, and they allow companies to sue governments if certain decisions are enacted that run counter to the interests of the company. The European parties and especially Germany are wary of such arbitration clauses. 

This issue is also relevant to intellectual property as the parties have chosen to include an opt-out clause for arbitration, allowing the domestic authorities full responsibility to determine the existence and validity of intellectual property rights.


Treaty Compliance

The final text of CETA regarding international trade-mark agreements goes a bit further than was anticipated. Parties are to make "reasonable efforts" to comply with the Singapore Treaty and to accede to the Madrid Protocol. Though CETA has only called for "reasonable efforts" and does not require accession to either treaty, Canada is well on its way to fulfilling its commitment.

In January 2014, the Canadian government tabled three trade-mark related international intellectual property agreements. including the Singapore Treaty and the Madrid Protocol. The Canadian government has taken steps to officially ratify and implement these international agreements. The implementation of the Madrid Protocol would bring Canada into line with over 90 countries and facilitate the registration of trade-marks in these different countries.

Counterfeit Goods

CETA also includes several commitments aimed at curtailing trade in counterfeit goods. Civil remedies and border enforcement rights will likely form much of Canada's obligations. These are consistent with Canada's anti-counterfeiting regime, and are in keeping with the proposals found in pending Bill C-8, the Combating Counterfeit Products Act, introduced to Canadian Parliament on October 28, 2013. The Bill is progressing more slowly than expected and has come under some criticism that its measures do not go far enough to combat counterfeiting. The House of Commons most recently debated Bill C-8 on September 19, 2014 and it remains stalled at the third reading stage.

While Bill C-8 is an encouraging development, concerns exist that further amendments to the proposed legislation may be required to enhance the effectiveness of Canada's anti-counterfeiting and anti-piracy regime, including  border enforcement, resource allocation, and the bearing of costs related to storage, handling and destruction of counterfeit goods. Additionally, the offences, punishment and remedy provisions may need further revisions if brand owners are to rely on these provisions to enforce their rights in a pragmatic and meaningful manner.

Geographical Indications (GIs)

Under CETA, Canada will provide protection for over 170 terms covering various foods and beer, in addition to those EU wines and spirits GIs currently recognized by Canada. The nature and scope of protection will vary depending upon the specific GI in question and will not prejudice any existing Canadian trade-mark holders.

There are a number of exceptions listed in the Agreement that will allow for different uses of certain GI protected terms.

For example, CETA preserves the right of Canadian producers to use customary common English and French terms for certain food products, such as the English and French, but not the German term for Black Forest ham. Other terms that continue to be free for use in Canada include Valencia orange, Tiroler bacon, Parmesan, St. George cheese, Bavarian beer, and Munich beer.

The GI rights provided to the EU with respect to certain cheese products, such as Asiago, Feta, Fontina, Gorgonzola and Munster, are also limited. While users that pre-date October 18, 2013 are unaffected, future users will be able to use the names only when accompanied by expressions such as "kind," "type," style," "imitation" or the like.

CETA also allows Canada to maintain the ability to use components of multi-part terms and customary names of animal and plant varieties. For example: "Brie de Meaux" will be protected, but the term "brie" can be used on its own.

GI protection for certain meat and cheese products will also be limited if a person or their successors had previously been using the term commercially for a period of either 5 or 10 years. If the term had been used for less than the time frame specified in the Agreement, then a transitional period will apply, after which use will no longer be permitted.

Ultimately, recognition and protection of GIs is expected to remain under the relevant legislation of each of the parties and a private matter to be determined by the Courts. Each party is also expected to adopt procedures for border enforcement to allow authorities to enforce GI-protected terms.


The copyright provisions of CETA are a reflection of already established international standards  from the 1996 World Intellectual Property Organization treaties: Copyright, and Performances and Phonograms. Canada's recent Copyright Modernization Act brought Canada's copyright regime into compliance with these international standards. The final draft is reflective of Canadian standards in the areas of protection of technological measures and intermediary service providers. As a result, no amendments to the Copyright Act are anticipated.


CETA calls for all parties to reinforce the protection of plant varieties based on the International Convention for the Protection of New Varieties of Plants. Canada's existing legal regime is compliant with the Convention, and CETA will not change the "farmers' privilege" to save and replant seeds of a protected variety on their own land under the federal Plant Breeders' Rights' Act, though there are amendments to the Act that are pending in Canadian Parliament under Bill C-18 introduced in December 2013. The Bill would expand the plant breeder's right to sue for damages for those who sell or reproduce their plants or seeds.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Events from this Firm
8 Nov 2016, Seminar, Ottawa, Canada

The prospect of an internal investigation raises many thorny issues. This presentation will canvass some of the potential triggering events, and discuss how to structure an investigation, retain forensic assistance and manage the inevitable ethical issues that will arise.

22 Nov 2016, Seminar, Ottawa, Canada

From the boardroom to the shop floor, effective organizations recognize the value of having a diverse workplace. This presentation will explore effective strategies to promote diversity, defeat bias and encourage a broader community outlook.

7 Dec 2016, Seminar, Ottawa, Canada

Staying local but going global presents its challenges. Gowling WLG lawyers offer an international roundtable on doing business in the U.K., France, Germany, China and Russia. This three-hour session will videoconference in lawyers from around the world to discuss business and intellectual property hurdles.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at and we will use commercially reasonable efforts to determine and correct the problem promptly.